SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘8-K’ for 6/9/21 – ‘EX-3.1’

On:  Thursday, 6/10/21, at 4:19pm ET   ·   For:  6/9/21   ·   Accession #:  1376339-21-85   ·   File #:  1-35887

Previous ‘8-K’:  ‘8-K’ on 6/3/21 for 5/27/21   ·   Next:  ‘8-K’ on / for 6/23/21   ·   Latest:  ‘8-K’ on / for 3/27/24   ·   9 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 6/10/21  Mimedx Group, Inc.                8-K:5,9     6/09/21   12:193K

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     27K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML     11K 
 3: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     10K 
 8: R1          Cover Page Document                                 HTML     48K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- mdxg-20210609_htm                   XML     23K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 5: EX-101.LAB  XBRL Labels -- mdxg-20210609_lab                     XML     70K 
 6: EX-101.PRE  XBRL Presentations -- mdxg-20210609_pre              XML     34K 
 4: EX-101.SCH  XBRL Schema -- mdxg-20210609                         XSD     10K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    18K 
12: ZIP         XBRL Zipped Folder -- 0001376339-21-000085-xbrl      Zip     15K 


‘EX-3.1’   —   Articles of Incorporation/Organization or Bylaws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 3.1
ARTICLES OF AMENDMENT
TO RESTATED ARTICLES OF INCORPORATION
OF
MIMEDX GROUP, INC.
TO DECLASSIFY THE BOARD OF DIRECTORS

FIRST: This Corporation is named MiMedx Group, Inc. (the “Corporation”). The Articles of Incorporation of the Corporation were originally filed with the Office of the Department of State of the State of Florida on February 8, 2008. The Restated Articles of Incorporation of the Corporation were filed with the Office of the Department of State of the State of Florida on March 4, 2021.

SECOND: Pursuant to the authority of the Board of Directors of the Corporation set forth in the Corporation’s Restated Articles of Incorporation and Section 607.0602 of the Florida Business Corporation Act (the “Act”), these Articles of Amendment were duly adopted by the Board of Directors of the Corporation on April 28, 2021 in accordance with the provisions of Section 607.1003 of the Act.

THIRD: These Articles of Amendment were duly approved by holders of a majority of the outstanding shares of the Common Stock and of the Preferred Stock of the Corporation, voting together as a single class, in accordance with the provisions of Section 607.1003 of the Act and the Corporation’s Restated Articles of Incorporation on May 27, 2021.

FOURTH: The Corporation’s Restated Articles of Incorporation are hereby amended by deleting Article 10(b) and inserting the following text in lieu thereof:

Article 10. Board of Directors. The business and the affairs of the Corporation shall be managed by, or under the direction of, a Board of Directors comprised as follows:

[…]

(b) The members of the Board of Directors elected at the 2010 annual meeting of Shareholders shall be divided into three classes, designated as Class I, Class II, and Class III as specified in the resolution adopted by Shareholders at such meeting. Each Class shall consist, as nearly as may be possible, of one-third of the total number of directors constituting the entire Board of Directors. The Class I directors elected at the 2010 annual meeting of Shareholders shall be deemed elected for a three-year term, Class II directors for a two-year term, and Class III directors for a one-year term. Each director shall hold office until the next annual meeting of Shareholders upon which his/her term expires and until his/her successor is elected and qualified, or until his/her earlier death, resignation or removal. At each succeeding annual meeting of Shareholders prior to the 2022 annual meeting, successor directors to the Class of directors whose term expires at that annual meeting of Shareholders shall be elected for a three-year term. If the number of directors has changed, any increase or decrease shall be apportioned among the Classes so as to maintain the number of directors in each Class as nearly equal as possible. Notwithstanding the foregoing, commencing with the 2022 annual meeting of Shareholders, each person nominated as a director to serve in the class of directors whose term shall expire at such annual meeting of Shareholders shall be elected to hold office for a term expiring at the next annual meeting of Shareholders and until his/her successor is elected and qualified or until his/her earlier death, resignation or removal. As a result, commencing with the 2024 annual meeting of Shareholders, the Board of Directors shall consist of one class of directors (with the Class I, Class II and Class III designations being eliminated), with all director nominees at such annual meeting of Shareholders and thereafter being elected to hold office for a term expiring at the next annual meeting of Shareholders and until his/her successor is elected and qualified or until his/her earlier death, resignation or removal.




IN WITNESS WHEREOF, the undersigned has executed these Articles of Amendment on May 27, 2021.


MiMedx Group, Inc.

By: /s/ William F. Hulse IV    
Name: William F. Hulse IV
Its: General Counsel and Secretary


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:6/10/21
For Period end:6/9/214
5/27/214,  8-K
4/28/2110-Q,  4,  8-K,  DEFA14A
3/4/213,  4
2/8/083,  3/A,  4,  8-K
 List all Filings 


9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Mimedx Group, Inc.                10-K       12/31/23  116:11M
 7/25/23  Mimedx Group, Inc.                S-8         7/25/23    5:94K                                    Donnelley … Solutions/FA
 7/25/23  Mimedx Group, Inc.                S-8         7/25/23    5:79K                                    Donnelley … Solutions/FA
 3/09/23  Mimedx Group, Inc.                S-8         3/09/23    5:88K                                    Donnelley … Solutions/FA
 2/28/23  Mimedx Group, Inc.                10-K       12/31/22  123:13M
 6/17/22  Mimedx Group, Inc.                S-8         6/17/22    5:85K                                    Donnelley … Solutions/FA
 2/28/22  Mimedx Group, Inc.                10-K       12/31/21  112:13M
 8/27/21  Mimedx Group, Inc.                S-3                    8:2.2M                                   Donnelley … Solutions/FA
 8/03/21  Mimedx Group, Inc.                10-Q        6/30/21   77:7.4M
Top
Filing Submission 0001376339-21-000085   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 12:30:29.1am ET